Table 3 Impact of testing on patient concerns about their prostate cancer.
Impact of test results | No. (%) of patients | Significant differences | Significant p values | |||
|---|---|---|---|---|---|---|
Overall [n = 485] | Positive [n = 55] | Negative [n = 215] | VUS-only [n = 215] | |||
Reduced my concerns a lot | 110 (22.7) | 5 (9.1) | 60 (27.9) | 45 (20.9) | Neg > Pos | 0.0009 |
Reduced my concerns somewhat | 95 (19.6) | 6 (10.9) | 47 (21.9) | 42 (19.5) | VUS > Pos | 0.0423 |
Increased my concerns somewhat | 23 (4.7) | 9 (16.4) | 5 (2.3) | 9 (4.2) | Pos > Neg | 0.0108 |
Increased my concerns a lot | 10 (2.1) | 1 (1.8) | 4 (1.9) | 5 (2.3) | ||
No change | 247 (50.9) | 34 (61.8) | 96 (44.7) | 117 (54.4) | NS | NS |
Impact of post-test counseling/ discussion with physician | No. (%) of patients | Significant differences | Significant p values | |||
|---|---|---|---|---|---|---|
Overall [n = 463] | Positive [n = 53] | Negative [n = 209] | VUS-only [n = 201] | |||
Reduced my concerns a lot | 98 (21.2) | 4 (7.5) | 54 (25.8) | 40 (19.9) | Neg > Pos | 0.0009 |
Reduced my concerns somewhat | 77 (16.6) | 6 (11.3) | 46 (22.0) | 25 (12.4) | ||
Increased my concerns somewhat | 18 (3.9) | 7 (13.2) | 3 (1.4) | 8 (4.0) | Pos > Neg | 0.0297 |
Increased my concerns a lot | 4 (0.9) | 0 (0.0) | 2 (1.0) | 2 (1.0) | ||
No change | 274 (59.2) | 36 (67.9) | 109 (52.2) | 129 (64.2) | NS | NS |
